InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Kalofonos Isabel, Directeur Commercial. Director active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. The latest transaction was filed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
US$86,6962,500 shares@ US$34.67850.0019% mcap100.0% of flow
Common Stock
SEC:0001628280-26-001230·
€86,6962,500 shares@ €34.67850.0019% mcap50.0% of flow
Common Stock
SEC:0001628280-26-001230:0·
2 of 2 declarations
About Kalofonos Isabel
Isabel Kalofonos serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. She is responsible for the company's commercial strategy and business development. Isabel brings expertise in sales management and business strategy, enabling her to drive growth initiatives. Her role is essential for achieving Crinetics' performance objectives.
